Biomarkers in drug development and regulation: a paradigm for clinical implementation of personalized medicine
Author:
Affiliation:
1. Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, US FDA, 10903 New Hampshire Avenue, Building 51 – Room 3182, Silver Spring, MD 20993, USA.
Abstract
Publisher
Future Medicine Ltd
Subject
Biochemistry, medical,Clinical Biochemistry,Drug Discovery
Link
https://www.futuremedicine.com/doi/pdf/10.2217/bmm.11.90
Reference30 articles.
1. The Path to Personalized Medicine
2. Anticipating Clinical Integration of Pharmacogenetic Treatment Strategies for Addiction: Are Primary Care Physicians Ready?
3. Genomics Education for Health Care Professionals in the 21st Century
4. Acceptance of Biomarker-Based Tests for Application in Clinical Practice: Criteria and Obstacles
Cited by 26 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Clinical pharmacogenetics;Atkinson's Principles of Clinical Pharmacology;2022
2. A multilaboratory validation study of LC/MS biomarker assays for three lysophosphatidylcholines;Bioanalysis;2021-10
3. Use of pharmacodynamic/response biomarkers for therapeutic biologics regulatory submissions;Biomarkers in Medicine;2019-07
4. Application of Ion Chromatography Coupled with Mass Spectrometry for Human Serum and Urine Metabolomics;SLAS DISCOVERY: Advancing the Science of Drug Discovery;2019-06-05
5. Governmental and Academic Efforts to Advance the Field of Pharmacogenomics;Pharmacogenomics;2019
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3